Peripherally Inserted Central Catheter Market by Catheter Type, End User, Design, Application, Material, Insertion Technique, Patient Age Group

Description

List of Tables

The Peripherally Inserted Central Catheter Market was valued at USD 985.26 million in 2023, expected to reach USD 1,031.79 million in 2024, and is projected to grow at a CAGR of 4.01%, to USD 1,297.63 million by 2030.

The market for Peripherally Inserted Central Catheters (PICCs) is primarily defined by the increasing demand for minimally invasive procedures in both hospital and home healthcare settings. PICCs are essential for long-term intravenous access, commonly used in patients requiring prolonged antibiotic therapy, chemotherapy, or total parenteral nutrition, which broadens their application and end-use scope significantly. Market growth is propelled by factors such as an aging population, rising incidences of chronic diseases like cancer and diabetes, and increasing healthcare expenditure, especially in emerging markets where healthcare infrastructure is expanding. Technological advancements, such as the development of antimicrobial and anti-thrombogenic PICCs, present significant growth opportunities. The growing preference for home healthcare services further accentuates the market's potential, as it drives the need for PICCs that enable patient mobility and comfort. However, the market faces challenges such as the high costs associated with PICC procedures, the risk of complications like infection and thrombosis, and the need for skilled personnel to insert and manage these devices. Regulatory complexities and the stringent approval process also pose hurdles to market expansion. To capitalize on potential opportunities, there is a need for innovation in the development of PICCs that reduce complications, incorporate advanced materials, and enhance patient outcomes. Research into cost-effective and easy-to-insert PICCs would be beneficial, catering to the increasing emphasis on outpatient care. The market is characterized by intense competition, with players vying for technological superiority to improve the safety and efficacy of their products. As healthcare shifts towards patient-centered models, collaborations between PICC manufacturers, healthcare providers, and research institutions could yield significant innovations. Companies should focus on strategic partnerships and expanding their product portfolios to adapt to evolving patient needs and regulatory environments, ensuring long-term market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 985.26 million
Estimated Year [2024]	USD 1,031.79 million
Forecast Year [2030]	USD 1,297.63 million
CAGR (%)	4.01%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Peripherally Inserted Central Catheter Market

The Peripherally Inserted Central Catheter Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increasing prevalence of chronic diseases necessitating long-term intravenous therapies
- Technological advancements in catheter design to enhance patient comfort and reduce infection rates
- Growing awareness and adoption of minimally invasive procedures among healthcare professionals and patients
- Rising investments in healthcare infrastructure and services in developing regions
Market Restraints
- Risk of complications associated with PICC usage
Market Opportunities
- Increasing demand for minimally invasive procedures enhancing market reach
- Technological advancements in catheter materials driving adoption rates
- Expanding healthcare infrastructure in emerging economies increasing market potential
Market Challenges
- Strict regulatory frameworks and approval procedures hindering swift market entry and product innovation

Porter's Five Forces: A Strategic Tool for Navigating the Peripherally Inserted Central Catheter Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Peripherally Inserted Central Catheter Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Peripherally Inserted Central Catheter Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Peripherally Inserted Central Catheter Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Peripherally Inserted Central Catheter Market

A detailed market share analysis in the Peripherally Inserted Central Catheter Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Peripherally Inserted Central Catheter Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Peripherally Inserted Central Catheter Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Peripherally Inserted Central Catheter Market

A strategic analysis of the Peripherally Inserted Central Catheter Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peripherally Inserted Central Catheter Market, highlighting leading vendors and their innovative profiles. These include 3M Health Care, AngioDynamics, Inc., Asahi Intecc Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Medical Inc., Fresenius Medical Care AG & Co. KGaA, Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, Merit Medical Systems, Inc., Nipro Corporation, Smiths Medical, Teleflex Incorporated, Terumo Corporation, Theragenics Corporation, and Vygon SA.

Market Segmentation & Coverage

This research report categorizes the Peripherally Inserted Central Catheter Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Catheter Type, market is studied across Double Lumen, Quad Lumen, Single Lumen, and Triple Lumen.
Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, Home Healthcare, and Hospitals.
Based on Design, market is studied across Non-Valved and Valved.
Based on Application, market is studied across Antibiotic Treatment, Chemotherapy, and Parenteral Nutrition.
Based on Material, market is studied across Polyurethane and Silicone. The Polyurethane is further studied across Advanced Polyurethane and Standard Polyurethane. The Silicone is further studied across Advanced Silicone and Standard Silicone.
Based on Insertion Technique, market is studied across Traditional and Ultrasound-Guided.
Based on Patient Age Group, market is studied across Adult, Geriatric, and Pediatric.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-9A6A6F2976B4

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of chronic diseases necessitating long-term intravenous therapies
  - 5.1.1.2. Technological advancements in catheter design to enhance patient comfort and reduce infection rates
  - 5.1.1.3. Growing awareness and adoption of minimally invasive procedures among healthcare professionals and patients
  - 5.1.1.4. Rising investments in healthcare infrastructure and services in developing regions
- 5.1.2. Restraints
  - 5.1.2.1. Risk of complications associated with PICC usage
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing demand for minimally invasive procedures enhancing market reach
  - 5.1.3.2. Technological advancements in catheter materials driving adoption rates
  - 5.1.3.3. Expanding healthcare infrastructure in emerging economies increasing market potential
- 5.1.4. Challenges
  - 5.1.4.1. Strict regulatory frameworks and approval procedures hindering swift market entry and product innovation
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Peripherally Inserted Central Catheter Market, by Catheter Type

6.1. Introduction
6.2. Double Lumen
6.3. Quad Lumen
6.4. Single Lumen
6.5. Triple Lumen

7. Peripherally Inserted Central Catheter Market, by End User

7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Clinics
7.4. Home Healthcare
7.5. Hospitals

8. Peripherally Inserted Central Catheter Market, by Design

8.1. Introduction
8.2. Non-Valved
8.3. Valved

9. Peripherally Inserted Central Catheter Market, by Application

9.1. Introduction
9.2. Antibiotic Treatment
9.3. Chemotherapy
9.4. Parenteral Nutrition

10. Peripherally Inserted Central Catheter Market, by Material

10.1. Introduction
10.2. Polyurethane
- 10.2.1. Advanced Polyurethane
- 10.2.2. Standard Polyurethane
10.3. Silicone
- 10.3.1. Advanced Silicone
- 10.3.2. Standard Silicone

11. Peripherally Inserted Central Catheter Market, by Insertion Technique

11.1. Introduction
11.2. Traditional
11.3. Ultrasound-Guided

12. Peripherally Inserted Central Catheter Market, by Patient Age Group

12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric

13. Americas Peripherally Inserted Central Catheter Market

13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Peripherally Inserted Central Catheter Market

14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Peripherally Inserted Central Catheter Market

15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

16. Competitive Landscape

16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.4. Strategy Analysis & Recommendation

Companies Mentioned

1. 3M Health Care
2. AngioDynamics, Inc.
3. Asahi Intecc Co., Ltd.
4. B. Braun Melsungen AG
5. Baxter International Inc.
6. Becton, Dickinson and Company
7. Boston Scientific Corporation
8. C. R. Bard, Inc.
9. Cardinal Health, Inc.
10. Cook Medical Inc.
11. Fresenius Medical Care AG & Co. KGaA
12. Lepu Medical Technology (Beijing) Co., Ltd.
13. Medtronic plc
14. Merit Medical Systems, Inc.
15. Nipro Corporation
16. Smiths Medical
17. Teleflex Incorporated
18. Terumo Corporation
19. Theragenics Corporation
20. Vygon SA